Regulations.gov document
Determination of Regulatory Review Period for Purposes of Patent Extension; MYCAMINE-NDA…
Notice · FDA-2006-E-0061 · posted Sep 26, 2006
Key facts
| Document ID | FDA-2006-E-0061-0009 |
|---|---|
| Title | Determination of Regulatory Review Period for Purposes of Patent Extension; MYCAMINE-NDA 21-506 - Federal Register Notice |
| Document type | Notice |
| Subtype | N-Notice |
| Agency | FDA |
| Docket | FDA-2006-E-0061 |
| Posted | Sep 26, 2006 |
| Comment period opens | Sep 25, 2006 |
| Comments due | Nov 28, 2006 |
At a glance
- 1–9 Pages
- No Open for comment
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: